Cadrenal Therapeutics (CVKD) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($3.3 million vs $3.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CVKD | SILO |
|---|---|---|
| Share price | $0.9296 | $1.45 |
| Market cap | $3.32M | $2.98M |
| 1-day change | -4.39% | +0.69% |
| EPS (TTM) | $-4.91 | $-4.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $10.44 |
| 52-week low | $0.85 | $1.30 |
| Distance from 52-week high | -93.59% | -86.11% |
| Average volume | 454.72K | 114.43K |
| Shares outstanding | 3.57M | 2.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CVKD vs SILO FAQ
Which is bigger, Cadrenal Therapeutics or Silo Pharma?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $3.32M compared with $2.98M for Silo Pharma (SILO).
Are Cadrenal Therapeutics and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.